<DOC>
	<DOC>NCT02018302</DOC>
	<brief_summary>This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.</brief_summary>
	<brief_title>Post Study Continuation of C7 for G1D</brief_title>
	<detailed_description>Only patients who completed the initial pilot study were eligible. The study is ongoing with these patients only.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Carbohydrate Metabolism, Inborn Errors</mesh_term>
	<criteria>Patients enrolled in the pilot trial (UTSW 122010186) Subjects who did not complete the pilot trial (UTSW 122010186)</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>28 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>G1D</keyword>
	<keyword>Glut1 Deficiency</keyword>
	<keyword>Glucose Transporter Type 1 Deficiency</keyword>
	<keyword>Glucose Transporter Type I Deficiency</keyword>
</DOC>